Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial.
Brunner HI, Ruperto N, Zuber Z, Keane C, Harari O, Kenwright A, Lu P, Cuttica R, Keltsev V, Xavier RM, Calvo I, Nikishina I, Rubio-Pérez N, Alexeeva E, Chasnyk V, Horneff G, Opoka-Winiarska V, Quartier P, Silva CA, Silverman E, Spindler A, Baildam E, Gámir ML, Martin A, Rietschel C, Siri D, Smolewska E, Lovell D, Martini A, De Benedetti F; Paediatric Rheumatology International Trials Organisation PRINTO; Pediatric Rheumatology Collaborative Study Group (PRCSG). Brunner HI, et al. Among authors: gamir ml. Ann Rheum Dis. 2015 Jun;74(6):1110-7. doi: 10.1136/annrheumdis-2014-205351. Epub 2014 May 16. Ann Rheum Dis. 2015. PMID: 24834925 Free PMC article. Clinical Trial.
Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open-Label, Randomized Study.
Quartier P, Alexeeva E, Constantin T, Chasnyk V, Wulffraat N, Palmblad K, Wouters C, I Brunner H, Marzan K, Schneider R, Horneff G, Martini A, Anton J, Wei X, Slade A, Ruperto N, Abrams K; Paediatric Rheumatology International Trials Organisation and the Pediatric Rheumatology Collaborative Study Group. Quartier P, et al. Arthritis Rheumatol. 2021 Feb;73(2):336-346. doi: 10.1002/art.41488. Epub 2020 Dec 11. Arthritis Rheumatol. 2021. PMID: 32783351 Free PMC article. Clinical Trial.
[Recommendations for the use of methotrexate in patients with juvenile idiopathic arthritis].
Calvo I, Antón J, López Robledillo JC, de Inocencio J, Gamir ML, Merino R, Lacruz L, Camacho M, Rua MJ, Bustabad S, Díaz Cordovés-Rego G. Calvo I, et al. Among authors: gamir ml. An Pediatr (Barc). 2016 Mar;84(3):177.e1-8. doi: 10.1016/j.anpedi.2015.05.005. Epub 2015 Jun 12. An Pediatr (Barc). 2016. PMID: 26077957 Free article. Spanish.
Consensus of the Spanish society of pediatric rheumatology for transition management from pediatric to adult care in rheumatic patients with childhood onset.
Calvo I, Antón J, Bustabad S, Camacho M, de Inocencio J, Gamir ML, Graña J, La Cruz L, Robledillo JC, Medrano M, Merino R, Modesto C, Nuñez E, Rua MJ, Torrente-Segarra V, Vargas C, Carmona L, Loza E. Calvo I, et al. Among authors: gamir ml. Rheumatol Int. 2015 Oct;35(10):1615-24. doi: 10.1007/s00296-015-3273-6. Epub 2015 Apr 28. Rheumatol Int. 2015. PMID: 25917856
Juvenile idiopathic arthritis in the young adult. Methodology, objectives, and initial data from the JUVENSER registry.
Bethencourt-Baute JJ, Montero N, Zacarias AM, Nieto JC, López-Corbeto M, Boteanu A, Medrano M, Díaz-Cordovés Rego G, Vargas-Lebron C, Machín-García S, Expósito L, Cacheda AP, Bernabeu P, Veroz-González R, Fernández O, Enriquez Merayo E, Torrente-Segarra V, Fernández-Alba MD, Gamir ML, López-Robledillo JC, Antón J, Otero L, Bustabad S. Bethencourt-Baute JJ, et al. Among authors: gamir ml. Reumatol Clin (Engl Ed). 2023 Jun-Jul;19(6):328-333. doi: 10.1016/j.reumae.2023.01.003. Epub 2023 May 29. Reumatol Clin (Engl Ed). 2023. PMID: 37258400 Free article.
Patient-Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two-Year Results From an International Phase III Study.
Ruperto N, Lovell DJ, Berman A, Ávila-Zapata F, Horneff G, Alessio M, Becker ML, Belot A, Burgos-Vargas R, Gamir ML, Goldenstein-Schainberg C, Scheibel IM, Terreri MT, Zemel L, Zhuo J, Askelson M, Wong R, Martini A, Brunner HI; Pediatric Rheumatology Collaborative Study Group and the Paediatric Rheumatology International Trials Organisation. Ruperto N, et al. Among authors: gamir ml. Arthritis Care Res (Hoboken). 2023 Aug;75(8):1804-1814. doi: 10.1002/acr.24989. Epub 2023 Jan 29. Arthritis Care Res (Hoboken). 2023. PMID: 36710243 Clinical Trial.
Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort.
Grasa CD, Fernández-Cooke E, Domínguez-Rodríguez S, Aracil-Santos J, Barrios Tascon A, Sánchez-Manubens J, Mercader B, Antón J, Nuñez E, Villalobos E, Bustillo M, Camacho M, Oltra Benavent M, Giralt G, Bello Naranjo AM, Rocandio B, Calvo C; Spanish group for the study of Kawasaki Disease (KAWA-RACE). Grasa CD, et al. Clin Rheumatol. 2022 Dec;41(12):3759-3768. doi: 10.1007/s10067-022-06319-4. Epub 2022 Aug 8. Clin Rheumatol. 2022. PMID: 35939163
28 results